BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D. Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments. World J Gastroenterol 2017; 23(33): 6030-6048 [PMID: 28970719 DOI: 10.3748/wjg.v23.i33.6030]
URL: https://www.wjgnet.com/1948-5182/full/v23/i33/6030.htm
(346) (351) (0) (0) (22765) (124)
Number Citing Articles
1
Guiqiang Wang, Atsushi Tanaka, Hong Zhao, Jidong Jia, Xiong Ma, Kenichi Harada, Fu-Sheng Wang, Lai Wei, Qixia Wang, Ying Sun, Yuan Hong, Huiying Rao, Cumali Efe, George Lau, Diana Payawal, Rino Gani, Keith Lindor, Wasim Jafri, Masao Omata, Shiv Kumar Sarin. The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatology International 2021; 15(2) doi: 10.1007/s12072-021-10170-1
2
Roberto Pertusa Mataix, José Salvador García Morillo, José Manuel Sousa Martín. Hepatic phenomena associated with SARS-CoV-2: Acute liver injury, autoimmune hepatitis and post-vaccination. Medicina Clínica (English Edition) 2025; 164(9) doi: 10.1016/j.medcle.2024.12.007
3
Julie R Brahmer, Hamzah Abu-Sbeih, Paolo Antonio Ascierto, Jill Brufsky, Laura C Cappelli, Frank B Cortazar, David E Gerber, Lamya Hamad, Eric Hansen, Douglas B Johnson, Mario E Lacouture, Gregory A Masters, Jarushka Naidoo, Michele Nanni, Miguel-Angel Perales, Igor Puzanov, Bianca D Santomasso, Satish P Shanbhag, Rajeev Sharma, Dimitra Skondra, Jeffrey A Sosman, Michelle Turner, Marc S Ernstoff. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events. Journal for ImmunoTherapy of Cancer 2021; 9(6) doi: 10.1136/jitc-2021-002435
4
Shahram Golbabapour, Kamran Bagheri-Lankarani, Saeid Ghavami, Bita Geramizadeh. Autoimmune Hepatitis and Stellate Cells: An Insight into the Role of Autophagy. Current Medicinal Chemistry 2020; 27(35) doi: 10.2174/0929867326666190402120231
5
Mirjam Kolev, Andreas E Kremer, Christiane Sokollik, Merill Eric Gershwin, Benedetta Terziroli Beretta-Piccoli, Raul J Andrade, Carina Bobzin, Ynto de Boer, Eleonora de Martin, Annamaria Deganello, Michael Heneghan, Gideon Hirschfield, Pietro Invernizzi, Tom H Karlsen, Antonio Lanzavecchia, Ansgar W Lohse, Maria S Longhi, Maria I Lucena, Michael Manns, Robert Mitchell-Thain, Christian Münz, Mike Recher, Marianne Samyn, Davide Salvioni, Ingo Van Thiel, Michael Trauner, Patrick van Rheenen, Yoh Zen. Unmet needs in autoimmune liver diseases. Current Opinion in Immunology 2025; 95 doi: 10.1016/j.coi.2025.102565
6
Laura E. Lavette, Mary S. McGrath, Sahil Khanna, Matthew K. Schliep, Taylor M. Horgan, Mira Sridharan, Brian J. Wentworth. Dosing and Route of Steroid Induction Therapy in Non‐Severe Autoimmune Hepatitis Do Not Affect Time to Biochemical Response. JGH Open 2026; 10(2) doi: 10.1002/jgh3.70371
7
Matthias Buechter, Dominik Dorn, Birte Möhlendick, Winfried Siffert, Hideo A. Baba, Guido Gerken, Alisan Kahraman. Characteristics and Long-Term Outcome of 535 Patients with Autoimmune Hepatitis—The 20-Year Experience of a High-Volume Tertiary Center. Journal of Clinical Medicine 2023; 12(13) doi: 10.3390/jcm12134192
8
Jimmy Daza, Lucas Soares Bezerra, Laura Santamaría, Roberto Rueda-Esteban, Heike Bantel, Marcos Girala, Matthias Ebert, Florian Van Bömmel, Andreas Geier, Andres Gomez Aldana, Kevin Yau, Mario Alvares-da-Silva, Markus Peck-Radosavljevic, Ezequiel Ridruejo, Arndt Weinmann, Andreas Teufel. Evaluation of four chatbots in autoimmune liver disease: A comparative analysis. Annals of Hepatology 2025; 30(1) doi: 10.1016/j.aohep.2024.101537
9
Sarah Petelinsek, Kasey Stoutin, Patrick Hughes, Alexander E Kolomaya. Rare Lupus Exacerbation Shines Light on Provider Bias in a Patient With Possible Autoimmune Hepatitis. Cureus 2025;  doi: 10.7759/cureus.98015
10
Elīna Vašuka, Vita Novika, Sniedze Laivacuma, Angelika Krūmiņa, Indra Zeltiņa. Clinical Features, Treatment Challenges and Outcomes of Patients with Autoimmune Hepatitis: Five Years Experience in Rīga East University Hospital. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 2024; 78(4) doi: 10.2478/prolas-2024-0038
11
Natanie J. Anilovich. Oral budesonide is an effective alternative to prednisone for treatment of autoimmune hepatitis. Clinical Research In Practice: The Journal of Team Hippocrates 2021; 7(2) doi: 10.22237/crp/1622160960
12
Saumya Pathak, Deepak Kamat. Autoimmune Hepatitis in Children. Pediatric Annals 2018; 47(2) doi: 10.3928/19382359-20180126-01
13
Marilena Durazzo, Giulia Lupi, Michela Scandella, Arianna Ferro, Gabriella Gruden. Autoimmune hepatitis treatment in the elderly: A systematic review. World Journal of Gastroenterology 2019; 25(22): 2809-2818 doi: 10.3748/wjg.v25.i22.2809
14
I. M. Iljinsky, O. M. Tsirulnikova. Historical aspects and current understanding of autoimmune hepatitis. When is liver transplantation indicated? (Review). Russian Journal of Transplantology and Artificial Organs 2022; 24(2) doi: 10.15825/1995-1191-2022-2-39-50
15
Artur Świerczek, Hanna Plutecka, Marietta Ślusarczyk, Grażyna Chłoń-Rzepa, Elżbieta Wyska. PK/PD Modeling of the PDE7 Inhibitor—GRMS-55 in a Mouse Model of Autoimmune Hepatitis. Pharmaceutics 2021; 13(5) doi: 10.3390/pharmaceutics13050597
16
Betul Aksoy, Masallah Baran, Yeliz Cagan Appak, Elif Sag, Murat Cakir, Burcu Guven, Sibel Yavuz, Busra Emir, Gokhan Tumgor. Efficiency of azathioprine monotherapy for maintenance treatment of autoimmune hepatitis in children. European Journal of Gastroenterology & Hepatology 2022; 34(1) doi: 10.1097/MEG.0000000000001930
17
Christina G. Plagiannakos, Gideon M. Hirschfield, Ellina Lytvyak, Surain B. Roberts, Marwa Ismail, Aliya F. Gulamhusein, Nazia Selzner, Karim M. Qumosani, Lawrence Worobetz, Julian Hercun, Catherine Vincent, Jennifer A. Flemming, Mark G. Swain, Angela Cheung, Tianyan Chen, Dusanka Grbic, Kevork Peltekain, Andrew L. Mason, Aldo J. Montano-Loza, Bettina E. Hansen. Treatment response and clinical event-free survival in autoimmune hepatitis: A Canadian multicentre cohort study. Journal of Hepatology 2024; 81(2) doi: 10.1016/j.jhep.2024.03.021
18
Diego Vergani, Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani. A reasoned approach to the treatment of autoimmune hepatitis. Digestive and Liver Disease 2021; 53(11) doi: 10.1016/j.dld.2021.05.033
19
Haiyan Fu, Yingchao Li, Gelan Bai, Runkai Yin, Chunlan Yin, Weina Shi, Lili Zhang, Rongpin Li, Ruiqin Zhao. Persistent cholestasis resulting from duodenal papillary carcinoma in an adolescent male. Medicine 2019; 98(22) doi: 10.1097/MD.0000000000015708
20
Ujunwa Korie, Albina Joldoshova, Binny Khandakar, Xuchen Zhang, Yuanxin Liang. Histopathology and its clinical correlation of liver biopsy in patients with treated autoimmune hepatitis. Annals of Diagnostic Pathology 2024; 73 doi: 10.1016/j.anndiagpath.2024.152333
21
Michael A. Heneghan, Elizabeth Shumbayawonda, Andrea Dennis, Refah Z. Ahmed, Mussarat N. Rahim, Michael Ney, Loren Smith, Matt Kelly, Rajarshi Banerjee, Emma L. Culver. Quantitative magnetic resonance imaging to aid clinical decision making in autoimmune hepatitis. eClinicalMedicine 2022; 46 doi: 10.1016/j.eclinm.2022.101325
22
Rithika Bhat, Antonio Tonutti, Suraj Timilsina, Carlo Selmi, M. Eric Gershwin. Perspectives on Mycophenolate Mofetil in the Management of Autoimmunity. Clinical Reviews in Allergy & Immunology 2023; 65(1) doi: 10.1007/s12016-023-08963-3
23
Marcos Mucenic. Advancements in autoimmune hepatitis management: Perspectives for future guidelines. World Journal of Hepatology 2024; 16(2): 135-139 doi: 10.4254/wjh.v16.i2.135
24
Sayan Malakar, Umair Shamsul Hoda, Suprabhat Giri, Arghya Samanta, Akash Roy, Rajat Gupta, S Rakesh Kumar, Mayank Agarwal, Anubhav Pawar, Sumit Rungta, Uday C Ghoshal. Difficult to treat and refractory autoimmune hepatitis: Recent advances in pharmacological management. World Journal of Hepatology 2025; 17(9): 110264 doi: 10.4254/wjh.v17.i9.110264
25
Tuğçe ÇAĞLAR, Azar ABİYEV, Özlem ERDEM, Murat KEKİLLİ, İbrahim DOĞAN. Otoimmün hepatit tanılı hastada azatioprin tedavisi sonrası gelişen Kaposi sarkomu. Akademik Gastroenteroloji Dergisi 2021; 20(2) doi: 10.17941/agd.978336
26
Yooyun Chung, Mussarat N Rahim, Jonathon J Graham, Yoh Zen, Michael A Heneghan. An update on the pharmacological management of autoimmune hepatitis. Expert Opinion on Pharmacotherapy 2021; 22(11) doi: 10.1080/14656566.2021.1895747
27
Benedetta Terziroli Beretta-Piccoli, Diego Vergani, Giorgina Mieli-Vergani. Autoimmune sclerosing cholangitis: Evidence and open questions. Journal of Autoimmunity 2018; 95 doi: 10.1016/j.jaut.2018.10.008
28
Kenneth W. Chow, Nguyen V. Pham, Britney M. Ibrahim, Kimberly Hong, Sammy Saab. Autoimmune Hepatitis-Like Syndrome Following COVID-19 Vaccination: A Systematic Review of the Literature. Digestive Diseases and Sciences 2022; 67(9) doi: 10.1007/s10620-022-07504-w
29
Keaton R. Jones, Craig S. Lammert. Management of Autoimmune Hepatitis Patients Refractory to or Intolerant of Standard Therapies. Current Hepatology Reports 2018; 17(3) doi: 10.1007/s11901-018-0401-2
30
Guillermo A. Costaguta, Fernando Álvarez. B cell depletion for autoimmune liver diseases: A retrospective review of indications and outcomes. JPGN Reports 2024; 5(3) doi: 10.1002/jpr3.12098
31
Giulia Jannone, Isabelle Scheers, Françoise Smets, Xavier Stephenne, Etienne M Sokal. Everolimus is Safe as a Second‐/Third‐Line Therapy in Pediatric Autoimmune Hepatitis. JPGN Reports 2022; 3(3) doi: 10.1097/PG9.0000000000000227
32
Simon Pape, Christoph Schramm, Tom JG Gevers. Clinical management of autoimmune hepatitis. United European Gastroenterology Journal 2019; 7(9) doi: 10.1177/2050640619872408
33
George Dalekos, Nikolaos Gatselis, Joost P. Drenth, Michael Heneghan, Marianne Jørgensen, Ansgar W. Lohse, Maria Londoño, Luigi Muratori, Maria Papp, Marianne Samyn, Dina Tiniakos, Ana Lleo. EASL Clinical Practice Guidelines on the management of autoimmune hepatitis. Journal of Hepatology 2025; 83(2) doi: 10.1016/j.jhep.2025.03.017
34
Leonard Kaps, María José Limeres, Paul Schneider, Malin Svensson, Yanira Zeyn, Silvia Fraude, Maximiliano L. Cacicedo, Peter R. Galle, Stephan Gehring, Matthias Bros. Liver Cell Type-Specific Targeting by Nanoformulations for Therapeutic Applications. International Journal of Molecular Sciences 2023; 24(14) doi: 10.3390/ijms241411869
35
Cong Meng, Yu Liu, Yuping Ming, Cao Lu, Yanggege Li, Yulu Zhang, Dongdong Su, Xueyun Gao, Qing Yuan. Enhancing Liver Delivery of Gold Nanoclusters via Human Serum Albumin Encapsulation for Autoimmune Hepatitis Alleviation. Pharmaceutics 2024; 16(1) doi: 10.3390/pharmaceutics16010110
36
Parth Shah, Vinay Sundaram, Einar Björnsson. Biologic and Checkpoint Inhibitor‐Induced Liver Injury: A Systematic Literature Review. Hepatology Communications 2020; 4(2) doi: 10.1002/hep4.1465
37
Ge Zhao, Hu Qi, Minghua Liu, Ting Zhou, Li Chen, Chunhong Wu, Xiongwei Zhang, Nan Zeng, Yue Tong. Rhoifolin Attenuates Concanavalin A-Induced Autoimmune Hepatitis in Mice via JAKs/STATs Mediated Immune and Apoptotic Processes. ACS Omega 2024; 9(42) doi: 10.1021/acsomega.4c07915
38
Haoran Chen, Zhongyu Han, Yiyue Fan, Liuyan Chen, Fang Peng, Xuhua Cheng, Yi Wang, Junyan Su, Dongxuan Li. CD4+ T-cell subsets in autoimmune hepatitis: A review. Hepatology Communications 2023; 7(10) doi: 10.1097/HC9.0000000000000269
39
Lydia T de Moraes Falcão, Debora R B Terrabuio, Marcio A Diniz, Andreia da Silva Evangelista, Fabricio G Souza, Eduardo L R Cancado. Efficacy and safety of chloroquine plus prednisone for the treatment of autoimmune hepatitis in a randomized trial. JGH Open 2020; 4(3) doi: 10.1002/jgh3.12258
40
Vikram K. Raghu, Robert H. Squires. Encyclopedia of Gastroenterology. 2020;  doi: 10.1016/B978-0-12-801238-3.66040-3
41
Luana Cagol, Teresa Seitel, Sarah Ehrenberg, Klara Frivolt, Andreas Krahl, Elke Lainka, Patrick Gerner, Henning Lenhartz, Jan Vermehren, Michael Radke, Stefan Trenkel, Benjamin Mayer, Sibylle Koletzko, Klaus-Michael Debatin, Thomas Mertens, Carsten Posovszky. Vaccination rate and immunity of children and adolescents with inflammatory bowel disease or autoimmune hepatitis in Germany. Vaccine 2020; 38(7) doi: 10.1016/j.vaccine.2019.12.024
42
Sanjay Kalra, Saptarshi Bhattacharya, Pawan Rawal. Hepatocrinology. Medical Sciences 2021; 9(2) doi: 10.3390/medsci9020039
43
Sherin J. Rouhani, Matthew J. Hadfield, Matthew Lei, Ross D. Merkin, Michael Dougan, Gabriela S. Hobbs, Sarah P. Hammond, Kerry L. Reynolds. Utilization of Steroid Sparing Agents for Immune-Related Adverse Events (irAEs): Management Strategies and Considerations. Current Oncology Reports 2026; 28(1) doi: 10.1007/s11912-026-01737-y
44
Zongye Jiang, Feng Xing. Applications of Emerging Technologies in Traditional Chinese Medicine of Chronic Liver Disease: Nanotherapy Integration with Relevance to Artificial Intelligence and Genomics. Revista Brasileira de Farmacognosia 2025; 35(6) doi: 10.1007/s43450-025-00696-y
45
Vincent Cheung, Tarun Gupta, Miranda Payne, Mark R Middleton, Jane D Collier, Alison Simmons, Paul Klenerman, Oliver Brain, Jeremy F Cobbold. Immunotherapy-related hepatitis: real-world experience from a tertiary centre. Frontline Gastroenterology 2019; 10(4) doi: 10.1136/flgastro-2018-101146
46
Marianne Zoghbi, Kathryn J. Burk, Elio Haroun, Maria Saade, Maria Teresa Cruz Carreras. Immune checkpoint inhibitor-induced diarrhea and colitis: an overview. Supportive Care in Cancer 2024; 32(10) doi: 10.1007/s00520-024-08889-2
47
Dieudonne Nonga, Maria Amendola, Jordan Serio, Mary Ayers, Amy Taylor, James E. Squires. Pediatric Autoimmune Hepatitis. Current Treatment Options in Pediatrics 2023; 9(3) doi: 10.1007/s40746-023-00271-4
48
Jing Luo, Zhe Yu, Wen An, Mengqi Li, Herui Wei, Ziteng Wang, Lingling He, Fan Xiao, Hongshan Wei. Tubuloside B alleviates con A-induced acute liver injury by inhibiting the IL-23/JAK2/STAT3 signaling pathway hyperactivation during Th17 cell differentiation. International Immunopharmacology 2025; 166 doi: 10.1016/j.intimp.2025.115586
49
Looi C Ee. Liver disease in the older child. Journal of Paediatrics and Child Health 2020; 56(11) doi: 10.1111/jpc.14708
50
Artur Świerczek, Bartosz Pomierny, Elżbieta Wyska, William J. Jusko. Pharmacokinetic/Pharmacodynamic Assessment of Selective Phosphodiesterase Inhibitors in a Mouse Model of Autoimmune Hepatitis. The Journal of Pharmacology and Experimental Therapeutics 2022; 381(2) doi: 10.1124/jpet.121.001004
51
Yiwen Hou, Chen Chen, Zhurong Li, Jiawen Wu, Sixue Lyu, Di Guo, Ying Liu, Yang Liu, Tiezheng Hou. Protective effect of quercetin against macrophage-mediated hepatocyte injury via anti-inflammation, anti-apoptosis and inhibition of ferroptosis. Autoimmunity 2024; 57(1) doi: 10.1080/08916934.2024.2350202
52
George Schatz, Erica Kumala, Amita Nathwani. A collaborative integrative and Ayurvedic approach to cirrhosis in the setting of autoantibody negative autoimmune hepatitis: a case report. Advances in Integrative Medicine 2022; 9(2) doi: 10.1016/j.aimed.2021.10.002
53
Kamil Janowski, Elizabeth Shumbayawonda, Andrea Dennis, Matt Kelly, Velicia Bachtiar, David DeBrota, Caitlin Langford, Helena Thomaides‐Brears, Maciej Pronicki, Wieslawa Grajkowska, Malgorzata Wozniak, Piotr Pawliszak, Sylwia Chełstowska, Elzbieta Jurkiewicz, Rajarshi Banerjee, Piotr Socha. Multiparametric MRI as a Noninvasive Monitoring Tool for Children With Autoimmune Hepatitis. Journal of Pediatric Gastroenterology and Nutrition 2021; 72(1) doi: 10.1097/MPG.0000000000002930
54
Wei Zhang, Jung-hyun Rho, Michael H. Roehrl, Julia Y. Wang. A comprehensive autoantigen-ome of autoimmune liver diseases identified from dermatan sulfate affinity enrichment of liver tissue proteins. BMC Immunology 2019; 20(1) doi: 10.1186/s12865-019-0304-1
55
Yuya Hirasawa, Kiyoshi Yoshimura, Hiroto Matsui, Yutaro Kubota, Hiroo Ishida, Jun Arai, Masashi Sakaki, Nao Oguro, Midori Shida, Makoto Taniguchi, Kazuyuki Hamada, Hirotsugu Ariizumi, Tomoyuki Ishiguro, Ryotaro Ohkuma, Takehiko Sambe, Atsushi Horiike, Chiyo K. Imamura, Eisuke Shiozawa, Satoshi Wada, Junji Tsurutani, Sanju Iwamoto, Naoki Uchida, Yuji Kiuchi, Genshu Tate, Shinichi Kobayashi, Takuya Tsunoda. A case report on severe nivolumab-induced adverse events similar to primary sclerosing cholangitis refractory to immunosuppressive therapy. Medicine 2021; 100(23) doi: 10.1097/MD.0000000000025774
56
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. The Rose and Mackay Textbook of Autoimmune Diseases. 2024;  doi: 10.1016/B978-0-443-23947-2.00074-6
57
Raúl Fabrizio Manchamé-Moreno, Christyan Arturo Borrayo-Alvarado. Hepatitis autoinmune inducida por drogas: asociación con nitrofurantoína. Revista Española de Casos Clínicos en Medicina Interna 2024; 9(3) doi: 10.32818/reccmi.a9n3a8
58
Akshaya Ramachandran, Drashti Antala , Prasun Pudasainee, Sreelakshmi Panginikkod, Harsh Gupta. A Plausible Association Between the Use of Elderberry and Autoimmune Hepatitis. Cureus 2022;  doi: 10.7759/cureus.24250
59
Yu. G. Sandler, E. V. Vinnitskaya, K. L. Raikhelson, K. V. Ivashkin, S. N. Batskikh, E. N. Aleksandrova, D. T. Abdurakhmanov, D. I. Abdulganieva, I. G. Bakulin, A. O. Bueverov, S. L. Vorobyev, O. A. Gerasimova, A. I. Dolgushina, M. S. Zhuravleva, L. Yu. Ilchenko, V. E. Karev, N. V. Korochanskaya, I. L. Kliaritskaia, N. S. Karnaukhov, S. V. Lapin, M. A. Livzan, M. V. Maevskaya, N. V. Marchenko, T. P. Nekrasova, I. G. Nikitin, A. A. Novikov, R. G. Saifutdinov, E. V. Skazyvaeva, V. E. Syutkin, M. K. Prashnova, T. Yu. Khaymenova, S. G. Khomerik. Diagnosis and Treatment of Patients with Autoimmune Hepatitis (Experts’ Agreement). Russian Journal of Gastroenterology, Hepatology, Coloproctology 2024; 34(6) doi: 10.22416/1382-4376-2024-34-6-100-119
60
Yuyan Huang, Yiwen Zhou, Xiaofeng Xu, Junmei Jiang, Zhaoyang Gou, Yi Lu, Xinbao Xie, Jianshe Wang, Zhuowen Yu. Development and validation of bleeding prediction model for percutaneous liver biopsy in children. BMC Pediatrics 2025; 26(1) doi: 10.1186/s12887-025-06341-w
61
Richard Taubert, Katharina Luise Hupa-Breier, Elmar Jaeckel, Michael P. Manns. Novel therapeutic targets in autoimmune hepatitis. Journal of Autoimmunity 2018; 95 doi: 10.1016/j.jaut.2018.10.022
62
Claudia Sîrbe, Alina Grama, Ancuţa Cutaş, Gabriel Benţa, Mara Puiu, Diana-Alexandra Borcău, Bianca Mariş, Simona Rednic, Tudor Lucian Pop. Treatment and outcomes of autoimmune hepatitis in children. Pediatru.ro 2022; 3(67) doi: 10.26416/Pedi.67.3.2022.7236
63
Yingzhou Shi, Hang Dong, Shiwei Sun, Xiaoqin Wu, Jiansong Fang, Jianbo Zhao, Junming Han, Zongyue Li, Huixiao Wu, Luna Liu, Wanhong Wu, Yang Tian, Guandou Yuan, Xiude Fan, Chao Xu. Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets. Clinical and Molecular Hepatology 2023; 30(1) doi: 10.3350/cmh.2023.0343
64
Zhen-Jun Yu, Lu-Lu Zhang, Ting-Ting Huang, Jian-Sheng Zhu, Ze-Bao He. Comparison of mycophenolate mofetil with standard treatment for autoimmune hepatitis: a meta-analysis. European Journal of Gastroenterology & Hepatology 2019; 31(7) doi: 10.1097/MEG.0000000000001367
65
Mara Cananzi, Marianne Hørby Jørgensen, Gustav Buescher, Ruth De Bruyne, Marianne Samyn. Current practice in the management of paediatric autoimmune liver disease in Europe. Journal of Pediatric Gastroenterology and Nutrition 2025; 80(2) doi: 10.1002/jpn3.12424
66
Hao Zhou, Qing Ye. Clinical Features of COVID-19 Vaccine-Associated Autoimmune Hepatitis: A Systematic Review. Diseases 2023; 11(2) doi: 10.3390/diseases11020080
67
Chrong-Reen Wang, Hung-Wen Tsai. Autoimmune liver diseases in systemic rheumatic diseases. World Journal of Gastroenterology 2022; 28(23): 2527-2545 doi: 10.3748/wjg.v28.i23.2527
68
Tarek A. Tamimi, Malik Sallam, Deema Rayyan, Randa Farah, Dana Alkhulaifat, Abdallah Al-Ani, Reem Elmusa, Said Sharawi, Omar Tanash, Yaser Rayyan. Clinical Characteristics of Autoimmune Hepatitis in a Middle Eastern Population: A Tertiary Care Center Experience. Journal of Clinical Medicine 2023; 12(2) doi: 10.3390/jcm12020629
69
Erasmo Miele, Marc A. Benninga, Ilse Broekaert, Jernej Dolinsek, Emmanuel Mas, Rok Orel, Corina Pienar, Carmen Ribes‐Koninckx, Rut A. Thomassen, Mike Thomson, Christos Tzivinikos, Nikhil Thapar. Safety of Thiopurine Use in Paediatric Gastrointestinal Disease. Journal of Pediatric Gastroenterology and Nutrition 2020; 71(2) doi: 10.1097/MPG.0000000000002802
70
Ruben De Wilde, Michael Saerens, Anne Hoorens, Anja Geerts, Celine Jacobs. Treatment of Refractory Checkpoint-Inhibitor-Induced Hepatitis with Tacrolimus: A Case and Review of the Literature. International Journal of Translational Medicine 2023; 3(3) doi: 10.3390/ijtm3030019
71
Jun Liu, Tingting Shen, Long Li, Xingyi Li, Fang Zhao, Xiaoxia Liu, Shan Zhang, Pengjia Wu, Na Li, Jiashun Zeng. A systemic lupus erythematosus patient with persistent elevated conjugated bilirubin as the initial symptom: A case report. Medicine 2024; 103(6) doi: 10.1097/MD.0000000000036999
72
Javad Moayedi, Ava Hashempour, Zahra Musavi, Farzaneh Ghasabi, Nastaran Khodadad, Mohamad Ali Davarpanah, Ali Hasanshahi. Assessment of human Herpes Virus-8 infection in Iranian cirrhotic patients on the waiting list for liver transplantation: A cross-sectional analysis. New Microbes and New Infections 2024; 62 doi: 10.1016/j.nmni.2024.101496
73
Angelo Del Gaudio, Federica Di Vincenzo, Valentina Petito, Maria Cristina Giustiniani, Antonio Gasbarrini, Franco Scaldaferri, Loris Riccardo Lopetuso. Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach. Inflammatory Bowel Diseases 2024; 30(6) doi: 10.1093/ibd/izad229
74
Pinelopi Arvaniti, Ignasi Olivas, Sergio Rodriguez-Tajes, George N. Dalekos, Maria-Carlota Londoño. Second- and third-line treatment agents in autoimmune hepatitis (AIH): Where do we stand?. Exploration of Digestive Diseases 2024;  doi: 10.37349/edd.2024.00042
75
Daniel D’Agostino, Maria Camila Sanchez, Gustavo Boldrini. Pediatric Hepatology and Liver Transplantation. 2019;  doi: 10.1007/978-3-319-96400-3_39
76
Wenwei Shao, Weilin Huang, Yixuan Wang, Helin Sima, Kai Ma, Rongtao Chen, Heqiao Han, Yixuan Yang, Yuchen Bao, Xiaolei Pei, Lei Zhang. Exosome-Modified AAV Gene Therapy Attenuates Autoimmune Hepatitis via Enhanced Regulatory T Cell Targeting and Immune Modulation. Microorganisms 2025; 13(4) doi: 10.3390/microorganisms13040823
77
Mamta Bajre, Mina Moawad, Elizabeth Shumbayawonda, Jane Elizabeth Carolan, Julie Hart, Emma Culver, Michael Heneghan. LiverMultiScan as an alternative to liver biopsy to monitor autoimmune hepatitis in the National Health Service in England: an economic evaluation. BMJ Open 2022; 12(9) doi: 10.1136/bmjopen-2021-058999
78
Yangfan Chen, Ruofei Chen, Haiyan Li, Zongwen Shuai. Clinical management of autoimmune liver diseases: juncture, opportunities, and challenges ahead. Immunologic Research 2025; 73(1) doi: 10.1007/s12026-025-09622-9
79
Hyun Goo Kang, Heesun Park, Ga Eun Myong, Woo Jeong Kim, Chae Eun Mun, Chae Rin Kim, Chae Yeon You, Su Kang Kim, Min Su Park, Sang-il Park. Beneficial Effect of Rapamycin on Liver Fibrosis in a Mouse Model (C57bl/6 Mouse). Transplantation Proceedings 2024; 56(3) doi: 10.1016/j.transproceed.2024.03.001
80
Tarini Ullal, Yoko Ambrosini, Sangeeta Rao, Cynthia R. L. Webster, David Twedt. Retrospective evaluation of cyclosporine in the treatment of presumed idiopathic chronic hepatitis in dogs. Journal of Veterinary Internal Medicine 2019; 33(5) doi: 10.1111/jvim.15591
81
Fares E.M. Ali, Mustafa Ahmed Abdel-Reheim, Emad H.M. Hassanein, Mostafa K. Abd El-Aziz, Hanan S. Althagafy, Khalid S.A. Badran. Exploring the potential of drug repurposing for liver diseases: A comprehensive study. Life Sciences 2024; 347 doi: 10.1016/j.lfs.2024.122642
82
Hydar El Jamaly, Guy D. Eslick, Martin Weltman. Systematic review with meta-analysis: autoimmune hepatitis in pregnancy. Scandinavian Journal of Gastroenterology 2021; 56(10) doi: 10.1080/00365521.2021.1953127
83
Fernando Álvarez, Guillermo Costaguta, Alejandro Costaguta. Autoimmune hepatitis: Towards a personalized treatment. World Journal of Hepatology 2024; 16(11): 1225-1242 doi: 10.4254/wjh.v16.i11.1225
84
Elisabeth Sucher, Robert Sucher, Tanja Gradistanac, Gerald Brandacher, Stefan Schneeberger, Thomas Berg. Autoimmune Hepatitis—Immunologically Triggered Liver Pathogenesis—Diagnostic and Therapeutic Strategies. Journal of Immunology Research 2019; 2019 doi: 10.1155/2019/9437043
85
Christoph F Dietrich, Dariusz Pietrawski, Ana Paula Barreiros, Christoph Klinger, Andrej Potthoff, Yi Dong. Ultrasound findings in autoimmune hepatitis. World Journal of Gastroenterology 2018; 24(15): 1583-1590 doi: 10.3748/wjg.v24.i15.1583
86
Benedetta Terziroli Beretta-Piccoli, Gustav Buescher, George Dalekos, Kalliopi Zachou, Anja Geerts, Nasser Semmo, Mirjam Kolev, Eleonora De Martin, Maciej K. Janik, João Madaleno, Milica Lalosevic Stojkovic, Jérôme Dumortier, Thomas Vanwolleghem, Ida Schregel, Silja Steinmann, Florence Lacaille, Marcial Sebode. Hepatic safety and efficacy of immunomodulatory drugs used in patients with autoimmune hepatitis. Journal of Autoimmunity 2023; 140 doi: 10.1016/j.jaut.2023.103113
87
Richard L. Pullen, Patricia Francis-Johnson. Inside autoimmune liver disease. Nursing Made Incredibly Easy! 2019; 17(1) doi: 10.1097/01.NME.0000549616.82525.47
88
Abel Vieira de Melo Bisneto, Amanda Silva Fernandes, Vivianne de Souza Velozo Sá, Jefferson Hollanda Véras, Estéfane Thaíne Sodré Soares, Aline Ferreira da Silva Santos, Clever Gomes Cardoso, Elisângela de Paula Silveira-Lacerda, Cristiene Costa Carneiro, Lee Chen-Chen. Anti-angiogenic activity of azathioprine. Microvascular Research 2021; 138 doi: 10.1016/j.mvr.2021.104234
89
Jessica Liu, Rami Hemadeh, Abdelrahman M. Attia, Pojsakorn Danpanichkul, Hasmik Adetyan, Naomy Kim, Tamar Yalda, Ju Dong Yang, Manaf Alsudaney, Walid Ayoub. Long-Term Prednisone Use Increases Hepatocellular Carcinoma Risk in Autoimmune Hepatitis Cirrhosis: A Retrospective Cohort Study. Gastro Hep Advances 2025; 4(10) doi: 10.1016/j.gastha.2025.100784
90
Yuanxin Liang, Xuchen Zhang. Practical Liver Pathology. Practical Anatomic Pathology 2025;  doi: 10.1007/978-3-031-97506-6_11
91
Thomas Lung, Benjamin Sakem, Lorenz Risch, Reinhard Würzner, Giuseppe Colucci, Andreas Cerny, Urs Nydegger. The complement system in liver diseases: Evidence-based approach and therapeutic options. Journal of Translational Autoimmunity 2019; 2 doi: 10.1016/j.jtauto.2019.100017
92
Paul A. Schmeltzer. Diagnosis and Management of Autoimmune Hepatitis. 2020;  doi: 10.1007/978-3-030-33628-8_6
93
Pedro Robson Costa Passos, Isabel Bastos de Medeiros, Tiago Franco David, Mateus Mendes Santos Freire, Letícia Pinheiro Amorim, Maria Julya Albuquerque Parente, Bartolomeu Feitosa Neto, Clébia Azevedo de Lima, Antônio Brazil Viana, Rodrigo Vieira Motta, Livia Melo Carone Linhares, Elodie Bomfim Hyppolito, Gustavo Rego Coelho, José Huygens Parente Garcia. Autoimmune Hepatitis Profiles After Liver Transplantation in Latin American Patients: A Cluster Analysis of Clinical Outcomes. Hepatology Research 2026; 56(3) doi: 10.1111/hepr.70069
94
Kamil Janowski, Elizabeth Shumbayawonda, Lin Cheng, Caitlin Langford, Andrea Dennis, Matt Kelly, Maciej Pronicki, Wieslawa Grajkowska, Malgorzata Wozniak, Piotr Pawliszak, Sylwia Chełstowska, Elzbieta Jurkiewicz, Rajarshi Banerjee, Piotr Socha. Quantitative multiparametric MRI as a non-invasive stratification tool in children and adolescents with autoimmune liver disease. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-94754-9
95
Romée JALM Snijders, Piotr Milkiewicz, Christoph Schramm, Tom JG Gevers. Health-related quality of life in autoimmune hepatitis. World Journal of Hepatology 2021; 13(11): 1642-1652 doi: 10.4254/wjh.v13.i11.1642
96
玉兰 朱. Diagnosis and Treatment of Autoimmune Hepatitis-Primary Biliary Cholangitis Overlap Syndrome. Advances in Clinical Medicine 2023; 13(03) doi: 10.12677/ACM.2023.133671
97
Bridgette B. McNally, Elizabeth J. Carey. Azathioprine Monotherapy Is Equivalent to Dual Therapy in Maintaining Remission in Autoimmune Hepatitis. Digestive Diseases and Sciences 2021; 66(5) doi: 10.1007/s10620-020-06347-7
98
Shun-Li Kuo, Chun-Han Su, Kuei-Hung Lai, Yu-Chia Chang, Jyh-Sheng You, Hsin-Hsin Peng, Chun-Hong Chen, Chi-Chen Lin, Po-Jen Chen, Tsong-Long Hwang. Guizhi Fuling Wan ameliorates concanavalin A-induced autoimmune hepatitis in mice. Biomedical Journal 2025; 48(1) doi: 10.1016/j.bj.2024.100731
99
Carlo Mainetti, Benedetta Terziroli Beretta-Piccoli, Carlo Selmi. Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review. Clinical Reviews in Allergy & Immunology 2017; 53(3) doi: 10.1007/s12016-017-8652-1
100
KASL clinical practice guidelines for management of autoimmune hepatitis 2022. Clinical and Molecular Hepatology 2023; 29(3) doi: 10.3350/cmh.2023.0087
101
Chengcheng Wang, Dongting Mao, Yanan Wei, Yanping Fu, Hongsheng Zhang. Clinical Significance and Factors Influencing T-Lymphocyte PD-1/PD-L1, Serum Autoimmune Antibodies and Erythrocyte Distribution Width in Patients with Autoimmune Hepatitis. Hepatitis Monthly 2025; 25(1) doi: 10.5812/hepatmon-161250
102
Dan Wang, Kaniel Cassady, Zhongmin Zou, Xi Zhang, Yimei Feng. Progress on the efficacy and potential mechanisms of rapamycin in the treatment of immune thrombocytopenia. Hematology 2022; 27(1) doi: 10.1080/16078454.2022.2151230
103
Lucas Rocha ALVARENGA, Natascha Silva SANDY, Gabriel HESSEL, Tiago Sevá PEREIRA, Maria Ângela BELLOMO-BRANDÃO. GOOD CORRELATION BETWEEN LIVER STIFFNESS MEASUREMENT AND APRI, FIB-4, PLATELET COUNT, IN PEDIATRIC AUTOIMMUNE HEPATITIS. Arquivos de Gastroenterologia 2024; 61 doi: 10.1590/s0004-2803.24612024-047
104
Simon Pape, Frederik Nevens, Chris Verslype, Caroline Mertens, Joost P.H. Drenth, Eric T.T.L. Tjwa. Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience. European Journal of Gastroenterology & Hepatology 2020; 32(6) doi: 10.1097/MEG.0000000000001580
105
Bilger Çavuş, Filiz Akyuz, Raim İliaz, Alp Atasoy, Umit Akyuz, Kadir Demir, Fatih Besisik, Sabahattin Kaymakoglu. Is there any predictor for relapse after treatment withdrawal in autoimmune hepatitis patients in the real life?. International Journal of Immunopathology and Pharmacology 2022; 36 doi: 10.1177/03946320221077860
106
Susan E. Fischer, Elsemieke S. de Vries, Maarten E. Tushuizen, Ynto S. de Boer, Adriaan J. P. van der Meer, Robert A. de Man, Johannes T. Brouwer, Johan P. Kuyvenhoven, Michael Klemt‐Kropp, Tom J. G. Gevers, Eric T. T. L. Tjwa, Edith M. M. Kuiper, Marc A. M. T. Verhagen, Philip W. Friederich, Bart van Hoek. Importance of complete response for outcomes of pregnancy in patients with autoimmune hepatitis. Liver International 2023; 43(4) doi: 10.1111/liv.15511
107
Nitipat Sandusadee, Wattana Sukeepaisarnjaroen, Tanita Suttichaimongkol. Prognostic factors for remission, relapse, and treatment complications in type 1 autoimmune hepatitis. Heliyon 2020; 6(4) doi: 10.1016/j.heliyon.2020.e03767
108
Ming-Hui Li, Yang Yang, Qi-Qi Dong, Wen-Jie Sun, Hui Tao, Jing-Jing Yang. Shining light on liquid–liquid phase separation in chronic liver disease. Drug Discovery Today 2025; 30(10) doi: 10.1016/j.drudis.2025.104464
109
Juliana Ximenes Damasceno, Maria Izabel Florindo Guedes, Christiane Araujo Chaves Leite, André Jalles Monteiro, Manasses Claudino Fonteles, Maria Esther Zurita Jimenez, Vilma de Lima, Thyciana Rodrigues Ribeiro, Cristiane Sá Roriz Fonteles. Salivary immunoglobulin levels in juvenile autoimmune hepatitis. Archives of Oral Biology 2018; 92 doi: 10.1016/j.archoralbio.2018.04.014
110
Katerina Bakela, Maria Georgia Dimitraki, Evangelia Skoufa, Irene Athanassakis. Rescue of autoimmune hepatitis by soluble MHC class II molecules in an altered concanavalin A‐induced experimental model. Animal Models and Experimental Medicine 2020; 3(3) doi: 10.1002/ame2.12133
111
Agata Mostkowska, Guy Rousseau, Noël J‐M Raynal. Repurposing of rituximab biosimilars to treat B cell mediated autoimmune diseases. The FASEB Journal 2024; 38(5) doi: 10.1096/fj.202302259RR
112
André Jefremow, Markus F. Neurath. New agents for immunosuppression. Best Practice & Research Clinical Gastroenterology 2021;  doi: 10.1016/j.bpg.2021.101763
113
Ifrah Fatima, Himil Mahadevia, Sheshadri Madhusudhana, Anuj Shrestha. Vanishing bile duct syndrome as a presentation of Hodgkin’s lymphoma. BMJ Case Reports 2024; 17(5) doi: 10.1136/bcr-2023-256818
114
Christiane Sokollik, Valerie A. McLin, Diego Vergani, Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani. Juvenile autoimmune hepatitis: A comprehensive review. Journal of Autoimmunity 2018; 95 doi: 10.1016/j.jaut.2018.10.007
115
Nora V. Bergasa. Clinical Cases in Hepatology. 2022;  doi: 10.1007/978-1-4471-4715-2_4
116
Nathalie A. Pena Polanco, Kalyan Ram Bhamidimarri. Hepatology. 2025;  doi: 10.1016/B978-0-443-26711-6.00026-3
117
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Autoimmmune hepatitis. Cellular & Molecular Immunology 2022; 19(2) doi: 10.1038/s41423-021-00768-8
118
Roberto Pertusa Mataix, José Salvador García Morillo, José Manuel Sousa Martín. Hepatic phenomena associated with SARS-CoV-2: Acute liver injury, autoimmune hepatitis and post-vaccination. Medicina Clínica 2025; 164(9) doi: 10.1016/j.medcli.2024.12.006
119
Ansgar W. Lohse, Marcial Sebode, Mette Vesterhus. Reply to: “Both tacrolimus and mycophenylate mophetil should be considered second-line therapy for autoimmune hepatitis”. Journal of Hepatology 2021; 74(3) doi: 10.1016/j.jhep.2020.11.031
120
Hubert Paweł Szyller, Martyna Wrześniewska, Julia Wołoszczak, Joanna Braksator, Tomasz Pytrus. Autoimmune hepatitis – an increasingly common cause of hypertransaminasaemia among children. Case report and literature review. Pediatria i Medycyna Rodzinna 2024; 20(2) doi: 10.15557/PiMR.2024.0021
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.